Back

Impact of functional autoantibodies against angiotensin-II receptor type 1 in atherosclerosis

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Artificial intelligence and cardiovascular disease (2) Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Giovanni Riccardo Maria Civieri

Padova Hospital, Padova (Italy)

7 More presentations in this session

Presentation thumbnail
HDLox and neuronal injury biomarkers as early signals of silent strokes after high thromboembolic risk transcatheter procedures
Associate Professor S. Tzikas (Thessaloniki, GR)
Abstract Slides Video
Presentation thumbnail
An inflammatory–hyperglycemic stress index predicts mortality in acute coronary syndrome: development and external validation in two large cohorts
Miss K. Zhang (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Simple ultrasound parameters-carotid plaque and coronary Doppler velocity at rest- predict cardiovascular events better than clinical risk factors: the PENSIAMOCI-PRIMA screening study.
Doctor F. Rigo (Dolo, IT)
Abstract Slides Video
Presentation thumbnail
Serum amyloid A as a predictor of coronary fatty plaque progression: a comparative analysis of cardiometabolic biomarkers
Doctor S. Ghay (Aventura, US)
Abstract Slides Video
Presentation thumbnail
Inflammatory resilience index combining hsCRP, albumin, and appendicular lean mass predicts functional limitations and mortality in U.S. adults: derivation and external validation study.
Doctor V. Jaiswal (Glenview, US)
Abstract Slides Video

Access the full session

Session thumbnail
Artificial intelligence and cardiovascular disease (2)

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
The biased angiotensin receptor 1-ligand TRV023 attenuates atherosclerosis through selective inhibition of Gq-mediated signaling
3 September 2019
thumbnail
Congress Presentation
Association between coronary inflammation measured by FAT attenuation index and CT features of atheromatous plaque vulnerability
10 May 2023
thumbnail
Congress Presentation
Plasma levels of amyloid beta 1-40 are associated with the rate of progression of carotid subclinical atherosclerosis in postmenopausal women
1 September 2019
thumbnail
Congress Presentation
Autoantibodies directed against apolipoprotein-a-1 as a potential contributor to non-alcoholic fatty liver disease
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources